Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013 - Wikidata - wikimedia - TriplyDB

Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013

Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013

http://www.wikidata.org/entity/Q33798369

about

Dissimilar Fitness Associated with Resistance to Fluoroquinolones Influences Clonal Dynamics of Various Multiresistant Bacteria Antimicrobial susceptibility of Clostridium difficile isolated in Thailand Clostridium difficile infection among hospitalized HIV-infected individuals: epidemiology and risk factors: results from a case-control study (2002-2013).A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.Longitudinal study of Clostridium difficile shedding in raccoons on swine farms and conservation areas in Ontario, Canada.Crystal structure and DNA binding activity of a PadR family transcription regulator from hypervirulent Clostridium difficile R20291.Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.Epidemiology of antimicrobial resistance in bloodstream infections.Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients.Two Novel Myoviruses from the North of Iraq Reveal Insights into Clostridium difficile Phage Diversity and Biology.DETECTION, RIBOTYPING AND ANTIMICROBIAL RESISTANCE PROPERTIES OF CLOSTRIDIUM DIFFICILE STRAINS ISOLATED FROM THE CASES OF DIARRHEA.Immune-based treatment and prevention of Clostridium difficile infection.Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study.Clostridium Difficile Infection from a Surgical Perspective.A Clostridium difficile Lineage Endemic to Costa Rican Hospitals Is Multidrug Resistant by Acquisition of Chromosomal Mutations and Novel Mobile Genetic Elements Molecular, microbiological and clinical characterization of Clostridium difficile isolates from tertiary care hospitals in Colombia.Recreational sandboxes for children and dogs can be a source of epidemic ribotypes of Clostridium difficile.Molecular typing and antimicrobial susceptibility testing to six antimicrobials of Clostridium difficile isolates from three Czech hospitals in Eastern Bohemia in 2011-2012.Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand.Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI.In vitro activity of surotomycin against contemporary clinical isolates of toxigenic Clostridium difficile strains obtained in Spain.CD2068 potentially mediates multidrug efflux in Clostridium difficile Subtyping of Clostridium difficile PCR ribotypes 591, 106 and 002, the dominant strain types circulating in Medellin, Colombia.Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).Antimicrobial Effect of Asiatic Acid Against Is Associated With Disruption of Membrane Permeability

P2860

Q26741585-88E4C01B-2381-4D16-A226-CB163D81BCCC Q33781513-4AA2B6D2-B31F-436E-B40E-97F41F8F2F1A Q35534395-8D093BC3-EA95-457E-8646-50F15C06E39C Q35677616-B9FD0B91-C325-444B-8A37-848929D32521 Q36076057-460E6310-F278-49DA-87E3-49356BF96160 Q36135109-F937C108-D636-449B-B04F-C702833ECB75 Q36156456-998201D1-B52B-4D49-96CE-0776FE41F7D3 Q36326824-DF599992-44F4-49D2-9ACB-F4DCDFDD0C17 Q36913239-DD9D953C-C67D-4390-B9EB-A9DB58BBF9A1 Q36970016-FE0998E0-952B-4C42-A673-B28E9D1C7A78 Q37119942-24C034C2-DDB9-4166-A990-CB7326AC865D Q37450187-D70D993A-7222-42E4-A78C-A1DF7DBE4BED Q37491761-62E67EA5-5193-43D5-BAE7-9C141CA26BBE Q38350907-B1EBF552-C425-4BD0-97C6-2FBE55B5649D Q38375999-70D1E538-0C3F-43B3-9141-A03A8698840E Q38445227-6ED8F57D-B0AF-4724-A73E-C211CA9C1529 Q39382890-8F079869-E72A-45CE-A120-D8A5D808CF3E Q40043401-D219908A-A423-436D-A721-9AF6F5FF84D8 Q40144431-8A93D372-DABC-4102-AC7E-481418E57770 Q40279012-14B2C0B2-A21D-4364-BD3E-830FC3F8AD00 Q40359443-3C42D51B-FE38-4570-8823-730C07BFD5FE Q40683812-EAE94F99-F8F7-4EDC-B736-BAC34C5613B3 Q41148829-E826B3E7-30C5-44C1-BF39-DAAC9F74C3D6 Q41148853-AD770DFC-5850-40FB-A059-E292E022BD09 Q41331732-7A1071A4-99B4-49ED-A476-2DA7382A1D68 Q41565399-A6E48E4E-7A70-4C34-8123-A2ACB375035A Q52323510-42900964-B736-4882-9AD7-446983B94AC7 Q53692769-D2998AE7-F3B6-48B8-810A-AD5698C65AAE Q55377810-EDAB5033-9AD3-4CAB-9DD1-E2B61A4BCF7D Q58758967-67DEDD00-AB8B-46F2-8054-49A270DB6C19

P2860

Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013

http://www.wikidata.org/entity/Q33798369

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Strain types and antimicrobial ...... he United States, 2011 to 2013

@ast

Strain types and antimicrobial ...... he United States, 2011 to 2013

@en

type

label

Strain types and antimicrobial ...... he United States, 2011 to 2013

@ast

Strain types and antimicrobial ...... he United States, 2011 to 2013

@en

prefLabel

Strain types and antimicrobial ...... he United States, 2011 to 2013

@ast

Strain types and antimicrobial ...... he United States, 2011 to 2013

@en

P1433

Q33798369-3D990499-8A02-4AB6-9028-FBE73022CDEE

P1476

Q33798369-B8F84477-8591-4E15-B14B-514EA4549C22

P2093

Q33798369-00DC75BB-454C-4511-A560-F4C4106A834E

Q33798369-63D8B824-32CA-4972-B353-137C971EF07F

Q33798369-8A7B3517-C069-41CA-A852-6A5A2EB0403D

Q33798369-8CCDCA5D-C638-4E40-9BBC-49FB06464AA2

Q33798369-AD6145D5-E55C-4981-8FC0-183D0EE6CCC0

Q33798369-F723C03C-7F00-446F-A0B4-A7D32476F7E2

P2860

Q33798369-246E52A7-88AE-4410-B343-9D925BDDC877

Q33798369-2BEAF6E1-1FF0-43E6-B87F-98BB9178A289

Q33798369-404C2E30-23CA-4FAE-9D29-8C35B859D673

Q33798369-4271DB26-BDEA-4651-8EDC-3B4875D25DA0

Q33798369-5C2A9A54-DD06-465F-938B-6C6B76D3ACB8

Q33798369-75CB7FBA-DB4A-440D-B91B-53131B14E3C3

Q33798369-7B5794C5-5334-447D-8CAF-EFD957D14488

Q33798369-7EBEB82B-AD3C-4935-B0E2-821B2A51A0DF

Q33798369-839D9E05-EC88-40DD-AF01-55EA673608C4

Q33798369-9714E769-D060-46D3-B53C-652D0B0121AF

P304

Q33798369-1253E487-5E3E-48C4-BC04-6EA9CFD773FB

P31

Q33798369-17521849-E55B-4785-B05D-AB856556109D

P356

Q33798369-62FDFAA1-51DA-45EE-8AE4-7566F3F699C5

P407

Q33798369-60D22A2F-705E-4874-BA02-24A459721BC1

P433

Q33798369-399EF332-F791-45F4-BED9-3A4CD3FA6AB3

P478

Q33798369-6B158D2E-9F54-4ED1-BC53-61C4C3388D47

P50

Q33798369-0E84158C-1ABD-4BE1-8DB1-B66538C0BCB8

P577

Q33798369-20B53FF8-0E77-4D7A-A8E3-75E4721E8671

P698

Q33798369-E2FA1954-79D6-439C-864F-64E38AC68ED3

P921

Q33798369-9C681106-0F30-47FC-BE1D-DA02E91D18DE

P932

Q33798369-1937A086-2D7E-4D6D-AFEB-45130A32393F

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Strain types and antimicrobial ...... he United States, 2011 to 2013

@en

P2093

Ashley N W Lynn

http://www.w3.org/2001/XMLSchema#string

David H Persing

http://www.w3.org/2001/XMLSchema#string

Fred C Tenover

http://www.w3.org/2001/XMLSchema#string

Healthcare Associated Infection Consortium

http://www.w3.org/2001/XMLSchema#string

Isabella A Tickler

http://www.w3.org/2001/XMLSchema#string

Joseph D Whitmore

http://www.w3.org/2001/XMLSchema#string

P2860

Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations.

Clostridium difficile genotypes other than ribotype 078 that are prevalent among human, animal and environmental isolates.

Comparison of strain typing results for Clostridium difficile isolates from North America.

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004

Antimicrobial-resistant strains of Clostridium difficile from North America.

Clostridium difficile in faeces from healthy dogs and dogs with diarrhea.

Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.

Clostridium difficile ribotype diversity at six health care institutions in the United States

Evaluation of the E test for susceptibility testing of anaerobic bacteria.

P304

4214-4218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02775-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Richard Goering

P577

2014-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24752264

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

4068552

http://www.w3.org/2001/XMLSchema#string